pentacle v.1.0.6 software (DWK Life Sciences)
90
Structured Review
DWK Life Sciences
pentacle v.1.0.6 software
Pentacle V.1.0.6 Software, supplied by DWK Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pentacle+v%2E1%2E0%2E6+software/met+idea+software/pm27495391-35-31-34
Average 90 stars, based on 1 article reviews
Pentacle V.1.0.6 Software, supplied by DWK Life Sciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pentacle+v%2E1%2E0%2E6+software/met+idea+software/pm27495391-35-31-34
Average 90 stars, based on 1 article reviews
pentacle v.1.0.6 software - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Novel aryl β-aminocarbonyl derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures. Article Snippet: Novel aryl β-aminocarbonyl derivatives as inhibitors of Trypanosoma cruzi trypanothione reductase: binding mode revised by docking and GRIND2-based 3D-QSAR procedures Carlos Henrique Tomich de Paula da Silva a , Lílian Sibelle Campos Bernardes a b , Vinícius Barreto da Silva a , Carlos Leomar Zani c & Ivone Carvalho a a Faculdade de Ciências Farmacêuticas de Ribeirão Preto, USP, Av. do Café S/N, CEP: 14040-903, Ribeirão Preto, SP, Brazil b Departamento de Ciências Farmacêuticas, Universidade Federal de Santa Catarina, Campus Universitário, Florianópolis, SC, CEP: 88040-970, Brazil c Laboratório de Química de Produtos Naturais, Centro de Pesquisas René Rachou, FIOCRUZ, Belo Horizonte, MG, CEP: 30190-002, Brazil Article Title: GRIND2-based 3D-QSAR and prediction of activity spectra for symmetrical bis-pyridinium salts with promastigote antileishmanial activity. Article Snippet: Leishmaniasis is a major group of neglected tropical diseases caused by the protozoan parasite Leishmania.. About 12 million people are affected in 98 countries and 350 million people worldwide are at risk of infection.. Current leishmaniasis treatments rely on a relatively small arsenal of drugs, including amphotericin B, pentamidine and others, which in general have some type of inconvenience. |